NZ189756A - Muramyl peptides antigens covalently bonded to muramyl-peptides medicaments and vaccines - Google Patents

Muramyl peptides antigens covalently bonded to muramyl-peptides medicaments and vaccines

Info

Publication number
NZ189756A
NZ189756A NZ189756A NZ18975679A NZ189756A NZ 189756 A NZ189756 A NZ 189756A NZ 189756 A NZ189756 A NZ 189756A NZ 18975679 A NZ18975679 A NZ 18975679A NZ 189756 A NZ189756 A NZ 189756A
Authority
NZ
New Zealand
Prior art keywords
muramyl
peptides
vaccines
medicaments
covalently bonded
Prior art date
Application number
NZ189756A
Inventor
G Baschang
A Hartmann
F Dietrich
L Tarcsay
R Gisler
J Stanek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27173419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ189756(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ189756A publication Critical patent/NZ189756A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NZ189756A 1978-02-24 1979-02-23 Muramyl peptides antigens covalently bonded to muramyl-peptides medicaments and vaccines NZ189756A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH203578 1978-02-24
CH377778 1978-04-07
CH539478 1978-05-18

Publications (1)

Publication Number Publication Date
NZ189756A true NZ189756A (en) 1982-05-31

Family

ID=27173419

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ189756A NZ189756A (en) 1978-02-24 1979-02-23 Muramyl peptides antigens covalently bonded to muramyl-peptides medicaments and vaccines

Country Status (20)

Country Link
EP (1) EP0003833B2 (en)
JP (1) JPS54141718A (en)
AR (1) AR223833A1 (en)
AT (1) AT364718B (en)
AU (1) AU527549B2 (en)
CA (1) CA1138436A (en)
DD (1) DD141616A5 (en)
DK (1) DK161026C (en)
ES (2) ES477977A1 (en)
FI (1) FI66878C (en)
GB (1) GB2015534A (en)
GR (1) GR77615B (en)
HU (1) HU182011B (en)
IL (1) IL56724A (en)
NO (2) NO151201C (en)
NZ (1) NZ189756A (en)
PL (1) PL123315B1 (en)
PT (1) PT69281A (en)
SU (1) SU1055312A3 (en)
ZA (1) ZA79893B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130516A (en) * 1978-03-31 1979-10-09 Yuuichi Yamamura Acyllnnacetylmuramylpeptide derivativeeantigen combination
FR2428050A1 (en) * 1978-06-05 1980-01-04 Anvar OLIGOMERS OF MURAMYL-PEPTIDE COMPOUNDS AND DRUGS CONTAINING THEM
FR2428051A1 (en) * 1978-06-05 1980-01-04 Anvar NOVEL MURAMYL-PEPTIDE COMPOUNDS AND MEDICAMENTS CONTAINING THEM
US4335111A (en) 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
FR2446292A1 (en) * 1979-01-12 1980-08-08 Anvar MURAMYL-PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM
FR2449697A1 (en) * 1979-02-20 1980-09-19 Anvar NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
DK156252C (en) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co METHOD OF ANALOGUE FOR THE PREPARATION OF DI, TRIAL OR TETRAPEPTIDE DERIVATIVES OR SALTS THEREOF
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
EP0038153A3 (en) * 1980-04-15 1982-12-22 Beecham Group Plc Modified allergens
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2522967B1 (en) * 1982-03-15 1986-03-07 Anvar CONJUGATES OF HAPTENES AND MURAMYL-PEPTIDES, WITH IMMUNOGENIC ACTIVITY AND COMPOSITIONS CONTAINING THEM
US4587046A (en) * 1982-05-18 1986-05-06 The Regents Of The University Of California Drug-carrier conjugates
FR2558165B1 (en) * 1984-01-17 1986-07-04 Anvar NOVEL CONJUGATES OF OLIGO-MURAMYLPEPTIDES AND BIOLOGICAL COMPOSITIONS CONTAINING THEM FOR THE ACTIVATION OF MACROPHAGES
FR2569984B1 (en) * 1984-09-12 1987-08-14 Anvar SYNTHETIC MOLECULE CONTAINING A PLURALITY OF SEPARATE EPITOPES, PROCESS FOR OBTAINING SAME AND APPLICATION TO THE PRODUCTION OF POLYVACCINES
EP4308105A1 (en) 2021-03-19 2024-01-24 Trained Therapeutix Discovery, Inc. Compounds for regulating trained immunity, and their methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH453269A4 (en) * 1968-03-29 1973-01-31
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
JPS52139018A (en) * 1976-03-10 1977-11-19 Anvar Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester
FR2343482A1 (en) * 1976-03-10 1977-10-07 Anvar LA 2- (2-ACETAMIDO-2-DEOXY-3-O-D-GLUCOPYRANOSYL) -D-PROPIONYL-L-SERYL-D-ISOGLUTAMINE AND MEDICINES CONTAINING IT

Also Published As

Publication number Publication date
AU527549B2 (en) 1983-03-10
FI790584A (en) 1979-08-25
FI66878C (en) 1984-12-10
AT364718B (en) 1981-11-10
FI66878B (en) 1984-08-31
PL123315B1 (en) 1982-10-30
DD141616A5 (en) 1980-05-14
PT69281A (en) 1979-03-01
ES483558A1 (en) 1980-04-16
ES477977A1 (en) 1980-01-16
JPH0130809B2 (en) 1989-06-22
ATA142079A (en) 1981-04-15
EP0003833A2 (en) 1979-09-05
IL56724A (en) 1982-12-31
NO151088C (en) 1985-02-06
GB2015534A (en) 1979-09-12
EP0003833B2 (en) 1990-12-19
NO151201C (en) 1985-02-27
AU4454679A (en) 1979-08-30
EP0003833A3 (en) 1980-02-06
NO790626L (en) 1979-08-27
SU1055312A3 (en) 1983-11-15
ZA79893B (en) 1980-03-26
HU182011B (en) 1983-12-28
DK161026B (en) 1991-05-21
CA1138436A (en) 1982-12-28
IL56724A0 (en) 1979-05-31
AR223833A1 (en) 1981-09-30
JPS54141718A (en) 1979-11-05
DK161026C (en) 1991-10-28
NO151088B (en) 1984-10-29
NO793993L (en) 1979-08-27
PL213696A1 (en) 1980-07-14
EP0003833B1 (en) 1983-07-20
DK79779A (en) 1979-08-25
GR77615B (en) 1984-09-25
NO151201B (en) 1984-11-19

Similar Documents

Publication Publication Date Title
NZ189756A (en) Muramyl peptides antigens covalently bonded to muramyl-peptides medicaments and vaccines
ZA794416B (en) Pasteurellois vaccines
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
GB8822749D0 (en) Vaccine containing tumour antigens & adjuvants
ZA793542B (en) Pharmaceutical preparations
DE2860875D1 (en) Immunological preparations incorporating mhc antigens and their production
MY8600529A (en) Dental preparations
NO842962L (en) PROCEDURE FOR PREPARING A POLYPEPTIDE SUITABLE FOR USE IN A VACCINATION PROCEDURE
NO792822L (en) ANTIGEN PREPARATION AND PROCEDURE FOR PREPARING THEREOF
AU1255383A (en) Foot and mouth disease viral antigenic peptides
ZA795039B (en) Pharmaceutical preparations
ZA794060B (en) Modified grass pollen antigens
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
GB2014984B (en) Pyrimidine-5-carboxamides the preparation and the therapeutical application thereof
IL51864A0 (en) Rabies vaccine and its preparation
ZA792691B (en) Anti-caries preparations
JPS5585524A (en) Respiratory tract vaccine and its manufacture
IL60370A0 (en) Polyvalent virus vaccine and its preparation
JPS5548439A (en) Nail and its preparation
GB2037161B (en) Preparations containing amino acids
JPS5589231A (en) Vaccine
DE2964881D1 (en) Parainfluenza virus vaccine and its preparation
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
JPS54102327A (en) Phthalon and preparation thereof
ZA793710B (en) Pharmaceutical preparations